SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

STERIS plc – ‘10-Q’ for 9/30/20 – ‘EX-31.1’

On:  Friday, 11/6/20, at 8:28am ET   ·   For:  9/30/20   ·   Accession #:  1757898-20-28   ·   File #:  1-38848

Previous ‘10-Q’:  ‘10-Q’ on 8/7/20 for 6/30/20   ·   Next:  ‘10-Q’ on 2/9/21 for 12/31/20   ·   Latest:  ‘10-Q’ on 2/8/24 for 12/31/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/06/20  STERIS plc                        10-Q        9/30/20   80:8.9M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    891K 
 2: EX-10.1     Material Contract                                   HTML     25K 
 3: EX-15.1     Letter re: Unaudited Interim Financial Info         HTML     24K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     27K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Document and Entity Information Document            HTML     75K 
14: R2          Consolidated Balance Sheets (Unaudited)             HTML    117K 
15: R3          Consolidated Balance Sheets (unaudited)             HTML     51K 
                Consolidated Balance Sheet (Parenthetical)                       
16: R4          Consolidated Statements of Operations (Unaudited)   HTML    113K 
17: R5          Consolidated Statements of Comprehensive Income     HTML     60K 
                (Unaudited)                                                      
18: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML    107K 
19: R7          CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY      HTML    128K 
                Statement                                                        
20: R8          Nature of Operations and Summary of Significant     HTML     59K 
                Accounting Policies(Notes)                                       
21: R9          Business Acquisitions and Divestitures Business     HTML     26K 
                Acquisitions and Divestitures (Notes)                            
22: R10         Inventories, Net (Notes)                            HTML     34K 
23: R11         Property, Plant and Equipment (Notes)               HTML     39K 
24: R12         Debt (Notes)                                        HTML     32K 
25: R13         Additional Consolidated Balance Sheets Information  HTML     57K 
                (Notes)                                                          
26: R14         Income Tax Expense (Notes)                          HTML     30K 
27: R15         Contingencies (Notes)                               HTML     29K 
28: R16         Business Segment Information (Notes)                HTML    131K 
29: R17         Shares and Preferred Shares (Notes)                 HTML     42K 
30: R18         Equity                                              HTML     26K 
31: R19         Share-Based Compensation (Notes)                    HTML     61K 
32: R20         Financial and Other Guarantees(Notes)               HTML     29K 
33: R21         Deritvatives and Hedging (Notes)                    HTML     46K 
34: R22         Fair Value Measurements (Notes)                     HTML     78K 
35: R23         Reclassifications out of Accumulated Other          HTML     70K 
                Comprehensive Income Reclassification out of                     
                Accumulated Other Comprehensive Income (Notes)                   
36: R24         Loans Receivable (Notes)                            HTML     26K 
37: R25         Restructuring (Notes)                               HTML     27K 
38: R26         Unusual or Infrequently Occurring Items             HTML     26K 
39: R27         Subsequent Events                                   HTML     27K 
40: R28         Nature of Operations and Summary of Significant     HTML     46K 
                Accounting Policies Accounting Policies (Policies)               
41: R29         Accounting Policies (Tables)                        HTML     40K 
42: R30         Inventories, Net Inventories, Net (Tables)          HTML     34K 
43: R31         Additional Consolidated Balance Sheets Information  HTML     92K 
                Additional Consolidated Balance Sheets Information               
                (Tables)                                                         
44: R32         Business Segment Information Business Segment       HTML    130K 
                Information (Tables)                                             
45: R33         Shares and Preferred Shares Shares and Preferred    HTML     42K 
                Shares (Tables)                                                  
46: R34         Share-Based Compensation Share-Based Compensation   HTML     60K 
                (Tables)                                                         
47: R35         Financial and Other Guarantees Financial and Other  HTML     28K 
                Gurantees (Tables)                                               
48: R36         Derivatives and Hedging Derivatives and Hedging     HTML     47K 
                (Tables)                                                         
49: R37         Fair Value Measurements Fair Value Measurements     HTML     76K 
                (Tables)                                                         
50: R38         Reclassifications out of Accumulated Other          HTML     69K 
                Comprehensive Income Reclassification out of                     
                Accumulated Other Comprehensive Income (Tables)                  
51: R39         Restructuring (Tables)                              HTML     27K 
52: R40         Nature of Operations and Summary of Significant     HTML     34K 
                Accounting Policies Revenue Table (Details)                      
53: R41         Business Acquisitions and Divestitures Fiscal 2018  HTML     39K 
                Acquisitions (Details)                                           
54: R42         Business Acquisitions and Divestitures Fiscal 2017  HTML     33K 
                Acquisitions (Details)                                           
55: R43         Business Acquisitions and Divestitures Fiscal 2017  HTML     32K 
                Divestitures (Details)                                           
56: R44         Business Acquisitions and Divestitures Revenues by  HTML     24K 
                Type (Details)                                                   
57: R45         Inventories, Net Inventories, Net (Details)         HTML     33K 
58: R46         Property, Plant and Equipment Property, Plant and   HTML     62K 
                Equipment (Details)                                              
59: R47         Debt Debt (Details)                                 HTML     45K 
60: R48         Additional Consolidated Balance Sheets Information  HTML     82K 
                Additional Consolidated Balance Sheets Information               
                (Details)                                                        
61: R49         Income Tax Expense Income Tax Expense (Details)     HTML     29K 
62: R50         Business Segment Information Business Segment       HTML     92K 
                Information (Details)                                            
63: R51         Shares and Preferred Shares Ordinary Shares         HTML     50K 
                (Details)                                                        
64: R52         Shares and Preferred Shares Preferred Shares        HTML     24K 
                (Details)                                                        
65: R53         Repurchases of Shares (Details)                     HTML     35K 
66: R54         Share-Based Compensation Share-Based Compensation   HTML    129K 
                (Details)                                                        
67: R55         Financial and Other Guarantees Financial and Other  HTML     29K 
                Guarantees (Details)                                             
68: R56         Derivatives and Hedging Fair Value of Derivatives,  HTML     60K 
                Balance Sheet Location (Details)                                 
69: R57         Derivatives and Hedging Gain (Loss) on              HTML     31K 
                Derivatives, Income Statement Location (Details)                 
70: R58         Fair Value Measurements Fair Value Hierarchy        HTML     73K 
                (Details)                                                        
71: R59         Fair Value Measurements Contingent Consideration    HTML     41K 
                Rollforward (Details)                                            
72: R60         Fair Value Measurements Available-for-sale          HTML     25K 
                securities (Details)                                             
73: R61         Reclassifications out of Accumulated Other          HTML     66K 
                Comprehensive Income Reclassification out of                     
                Accumulated Other Comprehensive Income (Details)                 
74: R62         Loans Receivable (Details)                          HTML     51K 
75: R63         Restructuring (Details)                             HTML     51K 
76: R64         Subsequent Events (Details)                         HTML     40K 
78: XML         IDEA XML File -- Filing Summary                      XML    143K 
12: XML         XBRL Instance -- ste-20200930_htm                    XML   2.16M 
77: EXCEL       IDEA Workbook of Financial Reports                  XLSX    104K 
 8: EX-101.CAL  XBRL Calculations -- ste-20200930_cal                XML    220K 
 9: EX-101.DEF  XBRL Definitions -- ste-20200930_def                 XML   1.00M 
10: EX-101.LAB  XBRL Labels -- ste-20200930_lab                      XML   1.99M 
11: EX-101.PRE  XBRL Presentations -- ste-20200930_pre               XML   1.16M 
 7: EX-101.SCH  XBRL Schema -- ste-20200930                          XSD    174K 
79: JSON        XBRL Instance as JSON Data -- MetaLinks              442±   653K 
80: ZIP         XBRL Zipped Folder -- 0001757898-20-000028-xbrl      Zip    340K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  


Exhibit 31.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
I, Walter M Rosebrough, Jr., certify that:
1.I have reviewed this quarterly report on Form 10-Q of STERIS plc;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
Date:November 6, 2020
/s/ WALTER M ROSEBROUGH, JR
Walter M Rosebrough, Jr.
President and Chief Executive Officer




Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/6/20None on these Dates
For Period end:9/30/20
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/01/21  Cantel Medical LLC                DEFM14A                1:5.7M                                   Broadridge Fin’l So… Inc
 4/01/21  STERIS plc                        424B3                  1:3.7M                                   Broadridge Fin’l So… Inc
 3/26/21  STERIS plc                        424B5                  1:1.4M                                   Donnelley … Solutions/FA
 3/24/21  STERIS plc                        424B5                  1:1.4M                                   Donnelley … Solutions/FA
 3/23/21  STERIS plc                        S-3ASR      3/23/21   23:3.1M                                   Donnelley … Solutions/FA


2 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/06/20  STERIS plc                        8-K:1,7,9  10/02/20   12:912K                                   Donnelley … Solutions/FA
 5/30/19  STERIS plc                        10-K        3/31/19  116:20M
Top
Filing Submission 0001757898-20-000028   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 5:26:48.1pm ET